» Articles » PMID: 22406534

The Sphingosine-1-phosphate Transporter Spns2 Expressed on Endothelial Cells Regulates Lymphocyte Trafficking in Mice

Abstract

The bioactive lysophospholipid mediator sphingosine-1-phosphate (S1P) promotes the egress of newly formed T cells from the thymus and the release of immature B cells from the bone marrow. It has remained unclear, however, where and how S1P is released. Here, we show that in mice, the S1P transporter spinster homolog 2 (Spns2) is responsible for the egress of mature T cells and immature B cells from the thymus and bone marrow, respectively. Global Spns2-KO mice exhibited marked accumulation of mature T cells in thymi and decreased numbers of peripheral T cells in blood and secondary lymphoid organs. Mature recirculating B cells were reduced in frequency in the bone marrow as well as in blood and secondary lymphoid organs. Bone marrow reconstitution studies revealed that Spns2 was not involved in S1P release from blood cells and suggested a role for Spns2 in other cells. Consistent with these data, endothelia-specific deletion of Spns2 resulted in defects of lymphocyte egress similar to those observed in the global Spns2-KO mice. These data suggest that Spns2 functions in ECs to establish the S1P gradient required for T and B cells to egress from their respective primary lymphoid organs. Furthermore, Spns2 could be a therapeutic target for a broad array of inflammatory and autoimmune diseases.

Citing Articles

Intrathymic Cell Migration: Implications in Thymocyte Development and T Lymphocyte Repertoire Formation.

Mendes-da-Cruz D, Lemos J, Belorio E, Savino W Adv Exp Med Biol. 2025; 1471:139-175.

PMID: 40067586 DOI: 10.1007/978-3-031-77921-3_5.


The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives.

Schwalm S, Manaila R, Oftring A, Schaefer L, von Gunten S, Pfeilschifter J Pflugers Arch. 2024; 476(12):1845-1861.

PMID: 39384640 PMC: 11582123. DOI: 10.1007/s00424-024-03029-5.


Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca channel.

Duse D, Schroder N, Srivastava T, Benkhoff M, Vogt J, Nowak M Basic Res Cardiol. 2024; 119(5):853-868.

PMID: 39110173 PMC: 11461684. DOI: 10.1007/s00395-024-01073-x.


Zonation and ligand and dose dependence of sphingosine 1-phosphate receptor-1 signalling in blood and lymphatic vasculature.

Del Gaudio I, Nitzsche A, Boye K, Bonnin P, Poulet M, Nguyen T Cardiovasc Res. 2024; 120(14):1794-1810.

PMID: 39086170 PMC: 11587562. DOI: 10.1093/cvr/cvae168.


Leveraging altered lipid metabolism in treating B cell malignancies.

Lee J, Mani A, Shin M, Krauss R Prog Lipid Res. 2024; 95:101288.

PMID: 38964473 PMC: 11347096. DOI: 10.1016/j.plipres.2024.101288.


References
1.
Pereira J, An J, Xu Y, Huang Y, Cyster J . Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol. 2009; 10(4):403-11. PMC: 2768754. DOI: 10.1038/ni.1710. View

2.
Sato K, Okajima F . Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein. World J Biol Chem. 2011; 1(11):327-37. PMC: 3083937. DOI: 10.4331/wjbc.v1.i11.327. View

3.
Lee Y, Venkataraman K, Hwang S, Han D, Hla T . A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat. 2007; 84(3-4):154-62. PMC: 2646377. DOI: 10.1016/j.prostaglandins.2007.08.001. View

4.
Kim R, Takabe K, Milstien S, Spiegel S . Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta. 2009; 1791(7):692-6. PMC: 2763566. DOI: 10.1016/j.bbalip.2009.02.011. View

5.
Kisanuki Y, Hammer R, Miyazaki J, Williams S, Richardson J, Yanagisawa M . Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001; 230(2):230-42. DOI: 10.1006/dbio.2000.0106. View